OptimizeRx Appoints Microsoft Health COO Mary Varghese Presti to Drive Subscription Revenue
OptimizeRx appointed Mary Varghese Presti, Microsoft Health & Life Sciences COO with over 25 years of healthcare technology experience, to its board of directors as an independent member. The company expects her expertise in scaling AI-powered platforms and post-merger integrations to accelerate its shift toward subscription-based recurring revenue.
1. Board Appointment Details
On April 8, 2026, OptimizeRx named Mary Varghese Presti as an independent director to its board as part of its ongoing board refresh and expansion process.
2. Executive Background
Presti serves as Corporate Vice President and COO of Microsoft’s Health & Life Sciences organization and brings more than 25 years of experience scaling healthcare and life sciences platforms, commercializing new technologies, and leading M&A integrations at Microsoft, IBM Watson Health, Nuance, athenahealth and Pfizer.
3. Strategic Implications for OptimizeRx
Her proven track record in operational strategy, AI-driven platform development and post-acquisition integration is expected to support OptimizeRx’s evolution into a product-led platform, boost recurring and subscription-based revenue, and accelerate growth of its AI-enabled patient and HCP engagement solutions.